Charles River Laboratories (CRL) reported fourth quarter adjusted EPS of $0.69 after the close Monday, compared to $0.60 in the prior year. The consensus estimate was for EPS of $0.56. Full year 2012 adjusted EPS is expected to come in between $2.60 and $2.70. The consensus estimate is for EPS of $2.64. The stock is now up 1.15 on 8K shares.
Charles River Laboratories gapped up slightly Monday, but traded in a range throughout the session. Shares finished up by 0.13 at $33.90.
For comments and feedback: editorial@rttnews.com